08 Jul 2009
Apple is facing an investigation by the US Securities and Exchange Commission (SEC) to determine whether the firm misled investors over the state of chief executive Steve Jobs's health, according to a Bloomberg report.
Jobs's physical condition has been a subject of deep concern for Apple shareholders, as the company's stock has fluctuated dramatically with each new revelation.
His gaunt appearance at last year's Worldwide Developers Conference led to a statement of reassurance from Apple in January that Jobs was not suffering from a resurgence of pancreatic cancer.
Jobs said at the time that he was suffering from a hormone imbalance, and would take a six-month leave of absence from the company. However, it emerged last month that Jobs had undergone a liver transplant.
Bloomberg said that the SEC will want to know what Apple's board of directors may have known when Jobs said that his illness was the result of hormone problems.
Latest stories from Finance
Related articles
Related jobs
Poll
What is the most important IT priority for your company this year?
Connect with V3.co.uk
This paper focuses on a series of best practices and techniques for development teams looking to improve their software development processes
Why good data management at all levels is essential in the modern business (video, 6mins)
Field/Site Engineering Manager/Leader Brief: Polar...
Product Manager, Open Repository (ref:BMC/PMR) End...
Java/J2EE Software Developer/Programmer - Dotcom/ eCommerce...
Field/Site Engineering Manager/Leader Brief: Polar...
Keep up to date with the latest products, services and technologies from the world's leading IT companies. IThound.com brings you over 2,000 white papers, case studies and analyst reports.
Do you agree?